Diagnostic Algorithm for Episodic Ataxia Types 1 and 2 in Resource-Limited Settings

A proposed clinical management algorithm for distinguishing episodic ataxia types EA1 and EA2, developed from a systematized literature review of confirmed genetic cases. The algorithm, tested on recent cases, achieved a sensitivity of 87.5% for identifying EA2. The 22.4 KB document by Claudio M. de Gusmao was last updated in April 2026 and is shared under a CC-BY-4.0 license.

Use Cases

• Developing a clinical decision support tool based on attack duration and symptom features.
• Training diagnostic models to differentiate EA1 from EA2 using triggers and attack frequency.
• Informing treatment selection (e.g., acetazolamide for EA2) based on the proposed algorithm.
• Benchmarking clinical diagnostic accuracy against genetic testing results.

Strengths

• Algorithm tested on a case cohort, yielding a reported sensitivity of 87.5% for EA2.
• Identifies specific clinical features with high diagnostic accuracy, such as attack duration <10 minutes for EA1 (75.3% sensitivity, 94.0% specificity).
• Explicitly designed for application in resource-limited clinical settings.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The data is contained in a 22.4 KB DOCX file, indicating a very limited scope, likely a supplementary document rather than a primary dataset.

Provenance

Source

figshare

Collection Method

Systematized literature review of individuals with confirmed pathogenic variants in KCNA1 and CACNA1A genes, followed by statistical analysis.

Time Range

Literature review includes cases described within the last three years prior to the study.

Freshness

Last updated 2026-04-21 14:38:15; freshness should be verified.

Geography

null